Skip to main content
Log in

The Alteration of Prostaglandin E2 Levels in Patients with Brain Tumors before and after Tumor Removal

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background. Both experimental and human tumors often synthesize high levels of prostaglandins, most notably prostaglandin E2 (PGE2). This compound may play an important role in tumor growth and immunosuppression. Little is known of the production of PGE2 by brain tumors. The present study was designed to investigate the levels of PGE2 in the plasma of human brain tumors before and after tumor removal.

Methods. The plasma PGE2 levels of brain tumors before and after tumor removal were measured by high-performance liquid chromatography (HPLC).

Results. There is a significantly high concentration of PGE2 in malignant brain tumor before tumor removal. Significantly decrease of PGE2 concentration after total removal of the tumor was found both in the malignant and benign brain tumor groups (P=0.0001 and P=0.0039 respectively). However, compared to the control group, only malignant brain tumor showed a significant decrease of PGE2 concentration after tumor removal (P=0.0009).

Conclusion. Our study demonstrates the malignant brain tumor synthesized higher relative proportions of PGE2 and surgical removal of the brain tumor can reduce the production of PGE2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tada M, De Tribolet N: Recent advances in immunobiology of brain tumors. J Neuro-Oncol 17: 261-271, 1993

    Google Scholar 

  2. Mahaley MS, Brooks WH, Bigner DD, Roszman TL: Immunobiology of primary intracranial tumors. I. Studies of the cellular and humoral general immune competence of brain tumor patient. J Neurosurg 46: 467, 1997

    Google Scholar 

  3. Brooks WH, Caldwell HD, Mortara RH: Immune responses in patients with gliomas. Surg Neurol 2: 419, 1974

    Google Scholar 

  4. Roszman T, Elliott L, Brooks W: Modulation of T-cell function by gliomas. Immnol Today 12: 370-374, 1991

    Google Scholar 

  5. Couldwell WT, Dore-Duffy P, Apuzzo MLJ, Antel JP: Malignant glioma modulation of immune function: relative contribution of different soluble factors. J Neuroimmunol 33: 89-96, 1991

    Google Scholar 

  6. Fontana A, Hengartner H, de Tribolet N, Weber E: Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2 mediated effects. J Immunol 132: 1837-1844, 1984

    Google Scholar 

  7. Lauro GM, Di Lorenzo N, Grossi M, Maleci A, Guidetti B: Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells. Acta Neuropathol 69: 278-282, 1986

    Google Scholar 

  8. Roszman TL, Brooks WH, Elliott LH: Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor. J Neurosurg 67: 874-879, 1987

    Google Scholar 

  9. Miescher S, Whiteside TL, de Tribolet N, Von Fliedner V: In situ characterization, clonogenic potential and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. J Neurosurg 68: 438-448, 1988

    Google Scholar 

  10. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A: Differential expression of transforming growth factor-B1, B2 and B3 by glioblastoma cells, astrocytes and microglia. J Immunol 148: 1404-1410, 1992

    Google Scholar 

  11. Sporn MB, Roberts AB: Transforming growth factor-B: recent progress and new challenges. J Cell Biol 119: 1017-1021, 1992

    Google Scholar 

  12. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyain E-dependent kinace by TGF-B. Science 260: 536-539, 1993

    Google Scholar 

  13. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW: Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1B. J Immunol 150: 2659-2667, 1993

    Google Scholar 

  14. Betz M, Fox BS: Prostaglandin E2 inhibits production of TH1 lymphokines but not of Th2 lymphokines. J Immunol 146: 108, 1991

    Google Scholar 

  15. Hilkens CM, Vermeulen H, Joost Van Neerven: Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 25: 59, 1995

    Google Scholar 

  16. Krstulovic AM: Investigations of catecholamine metabolism using HPLC. J Chromatogr 229: 1-34, 1982

    Google Scholar 

  17. Holly JMP, Makin HLJ: The estimation of catecholamines in human plasma. Anal Biochem 126: 257-274, 1983

    Google Scholar 

  18. Anagnostopoulos-Schleep J, Schlegel W, Krähling KH, König HJ: Prostaglandins F2á and E2 as possible mediatiors of peritumoral brain edema. Adv Neurosurg 16: 243-249, 1988

    Google Scholar 

  19. Köko¢glu E, Tüter Y, Sandikci KS, Yazici Z, Ulako¢glu E2, Sönmez H, Özyurte E: Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors. Cancer Lett 132: 17-21, 1998

    Google Scholar 

  20. Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P, Paoletti P: Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 49: 1505-1508, 1989

    Google Scholar 

  21. Cooper C, Jones HG, Weller RO, Walker V: Production of prostaglandins and thromboxane by isolated cells from intracranial tumors. J Neurol Neurosurg Psychiatry 47: 579-584, 1984

    Google Scholar 

  22. Chouaib S, Robb RJ, Weite K, Dupont B: Analysis of Prostaglandin E2 effect on T lymphocyte activation. J Clin Invest 80: 333-340, 1987

    Google Scholar 

  23. Eddleston M, Mucke L: Moleculor profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 54: 15-36, 1993

    Google Scholar 

  24. Goodwin JS: Prostaglandin synthetase inhibitors as immunoadjuvants in treatment of cancer. J Immunopharmacol 2: 397-424, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loh, JK., Hwang, SL., Lieu, AS. et al. The Alteration of Prostaglandin E2 Levels in Patients with Brain Tumors before and after Tumor Removal. J Neurooncol 57, 147–150 (2002). https://doi.org/10.1023/A:1015782809966

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015782809966

Navigation